文献速递肿瘤 PET/CT骨显像与常规 SPECT

99mTc-HYNIC-PSMA-11显像检测前列腺癌腹膜癌病

Detection of Peritoneal Carcinomatosis in Prostate Cancer via 99m Tc-HYNIC-PSMA-11 Scintigraphy.
PubMed 文献 · Clin Nucl Med · 2025-07-01

一例73岁新发转移性前列腺癌患者,在接受化疗和雄激素剥夺治疗(ADT)期间血清前列腺特异性抗原(PSA)水平升高,遂转诊重新分期。99mTc-HYNIC-PSMA-11显像显示腹膜腔摄取,全身扫描最初解释为肠道正常排泄,后经SPECT/CT明确。本病例强调功能显像在评估腹膜受累方面可能优于软组织分辨率有限的CT等解剖显像。

要点

  • 99mTc-HYNIC-PSMA-11显像可显示前列腺癌腹膜腔摄取,SPECT/CT有助于鉴别肠道排泄与腹膜病变。
  • 功能显像在评估腹膜受累方面可能超越软组织分辨率有限的CT等解剖显像。
  • ADT期间PSA升高提示需重新分期,PSMA显像可提供额外信息。

核心结论

  • 本病例强调功能显像(即使是常规方法)在评估腹膜受累方面可能超越软组织分辨率有限的CT等解剖显像。

研究设计与样本

  • 本文为个案报道,报告一例73岁新发转移性前列腺癌患者。

主要发现

  • 患者在接受化疗和雄激素剥夺治疗(ADT)期间血清前列腺特异性抗原(PSA)水平升高,遂转诊重新分期。
  • 99mTc-HYNIC-PSMA-11显像显示腹膜腔摄取,全身扫描最初解释为肠道正常排泄,后经SPECT/CT成像明确。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We present a 73-year-old man with de novo metastatic prostate cancer who had received chemotherapy and androgen deprivation therapy (ADT). An increase in his serum prostate-specific antigen (PSA) level during ADT prompted a referral for restaging. A 99m Tc-HYNIC-PSMA-11 scintigraphy was conducted, which revealed uptake in the peritoneal cavity that was initially interpreted as normal intestinal excretion on the whole body scan but was later clarified through SPECT/CT imaging. This case underscores the potential of functional imaging, even conventional methods, to surpass anatomical imaging techniques such as CT scans, which have limited soft tissue resolution, in assessing peritoneal involvement.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Raeisi N, Saber Tanha A, Aghaee A, et al. Detection of Peritoneal Carcinomatosis in Prostate Cancer via 99m Tc-HYNIC-PSMA-11 Scintigraphy. Clin Nucl Med. 2025. PMID: 40590111. doi:10.1097/RLU.0000000000005996

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。